Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 11916548

Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2002 Mar
First author
Taïeb J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2002 Mar;38(5):635-8. doi: 10.1016/s0959-8049(01)00419-1.
    note
    Source null
    related pmid
    11916543
    relationship
    Comment in

Authors and identifiers

  1. name
    Taïeb J
    type
    Author
  2. name
    Artru P
    type
    Author
  3. name
    Baujat B
    type
    Author
  4. name
    Mabro M
    type
    Author
  5. name
    Carola E
    type
    Author
  6. name
    Maindrault F
    type
    Author
  7. name
    Tournigand C
    type
    Author
  8. name
    Krulik M
    type
    Author
  9. name
    Louvet C
    type
    Author
  10. name
    de Gramont A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Taïeb J
    type
    Author
  2. name
    Artru P
    type
    Author
  3. name
    Baujat B
    type
    Author
  4. name
    Mabro M
    type
    Author
  5. name
    Carola E
    type
    Author
  6. name
    Maindrault F
    type
    Author
  7. name
    Tournigand C
    type
    Author
  8. name
    Krulik M
    type
    Author
  9. name
    Louvet C
    type
    Author
  10. name
    de Gramont A
    type
    Author
bibliography ids
  1. nci-bib-9af000ab678cd2916c228045
book metadata
content sha256
6a8213e83386318da727e71d69ccd3d090fed144f783b4f26be9da575ea31c08
document type
citation
dois
  1. 10.1016/s0959-8049(01)00400-2
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:11916548
immutable id
pubmed:11916548@6a8213e83386318da727e71d69ccd3d090fed144f783b4f26be9da575ea31c08
journal
abbreviation
Eur J Cancer
issn electronic
Source null
issn print
0959-8049
issue
5
name
European journal of cancer (Oxford, England : 1990)
nlm unique id
9005373
pages
661-6
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2002 Mar;38(5):635-8. doi: 10.1016/s0959-8049(01)00419-1.
    note
    Source null
    related pmid
    11916543
    relationship
    Comment in
outcomes validated
false
pmid
11916548
provenance
batch id
d4e82e28940c878dd0a2
provider
NCBI PubMed ESummary
record sha256
b1d56043d4948a058da713fa90493f62d8adf6f7328d971310593f92013f8920
response sha256
257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
retrieved at
2026-09-09T23:45:44.017762+00:00
publication date
display
2002 Mar
precision
month
year
2002
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase II
  3. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/11916548/
title
Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer.

Preserved source evidence · Not medical advice